Thomas Shehab - Profile and Investment Details

Investor Profile

Thomas Shehab is a Venture Capital, Private Equity Firm, Investor based in Ann Arbor, Michigan, United States with a diverse investment portfolio that includes companies such as Inogen, Cardiac Dimensions, IHA - Integrated Health Associates, Aira, Strata Oncology, Fifth Eye Inc., Esperion Therapeutics, Concerto Healthcare, Tangent Medical Technologies, Asterand, Rethink First, Saint Joseph Mercy Health System, SI-BONE, Koya Medical, Jumpcode Genomics, NxTheraMotif Neurotech, Accuri Cytometers, HandyLab, Swift Biosciences, Advance Medical, Mirabilis Medical, NeuMoDx Molecular, Fifth Eye, Wellfount, Flosonics, Bowling Green State University, nVision Medical, Fidelis SeniorCare, Pear Therapeutics, Health Scholars, SonarMD, EQRx, Delphinus Medical Technologies, Uptake Medical, BAROnova, ArborMetrix, Francis Medical, CardioMEMS, Boomerang Medical, KFx Medical, My Health Direct, Sonitus Medical, Virtual Incision, Intellicyt, Ebb Therapeutics, BioIQ, Cervilenz, NeoGuide Systems, Avation Medical, PathCentral, Adavium, Hicuity Health, Inc., Lucina Health, . Over time, Thomas Shehab has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Thomas Shehab is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Hospitals, Wellness, Women Founded, Life Science, Portfolio Management, Analytics, Software, Biotechnology, Medical Devices, Clinical Trials, Consumer Internet, Digital Health, Medical, SaaS, Information Technology, B2B, Therapeutics, Molecular Diagnostics, Media and Entertainment, Diverse Founder Investments, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Thomas Shehab, as their portfolio suggests a familiarity and interest in this area.

Understanding Thomas Shehab’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.